CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Modernatx against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025
Combination Of Vaccination And Inhibition Of The Pd-1 PathwayCUREVACMay 22, 2018
Novel Lipid Formulations For Nucleic Acid DeliveryARBUTUS BIOPHARMAApr 5, 2018

Explore Modernatx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 12, 2025Compounds And Compositions For Intracellular Delivery Of Agents1
Oct 2, 2024High-Purity Peg Lipids And Uses Thereof6
Sep 4, 2024Engineered Nucleic Acids And Methods Of Use Thereof2
May 8, 2024Methods Of Preparing Lipid Nanoparticles1
Feb 14, 2024Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs1
Jul 12, 2023Ribonucleic Acid Purification1
May 24, 2023Modified Messenger Rna Comprising Functional Rna Elements2
Nov 2, 2022Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof2
Oct 12, 2022Infectious Disease Vaccines1
May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof9

Top competitors of Modernatx

List of top competitors of Modernatx based on patent oppositions.